James A. Haley VAHTampa, United States
Disclosure information not submitted.
MON-044 - Evaluation of NPC86, A GAS5-Targeting Therapeutic, as A Modulator of Insulin Signaling in A Tauopathy Model
Monday, June 15, 20269:00 AM - 2:00 PM CT
MON-680 - Functional Differences in the Secretomes of Different Adipose Depots Promote Distinct Immune Responses to Injuries.